Clinical and Molecular Hepatology10.3350/cmh.2021.00722021272281-282Another oral antiviral treatment, but still far away from hepatitis B virus cureTai-Chung Tseng,,
Liver International10.1111/liv.136732018387-13Treatment of hepatitis C virus infection with direct-acting antiviral agents: 100% cure?Tarik Asselah, Patrick Marcellin, Raymond F. Schinazi,
Antiviral Research10.1016/0166-3542(94)90118-x19942317-18Oral session IV: Respiratory and hepatitis virus infections,
Antiviral Research10.1016/0166-3542(95)00923-x199629177-82Summary: antiviral treatment of hepatitis C virusG.M. Dusheiko,
Hepatitis C - From Infection to Cure10.5772/intechopen.759162018Hepatitis C Virus and InflammationBinod Kumar, Akshaya Ramachandran, Gulam Waris
Antiviral Research10.1016/j.antiviral.2015.07.0062015121152-159Treatment of chronic hepatitis B with pattern recognition receptor agonists: Current status and potential for a cureJinhong Chang, Ju-Tao Guo,
Hepatitis C Virus10.1017/cbo9780511545320.0192002135-140Antiviral gene therapy
Journal of Viral Hepatitis10.1111/jvh.181_12923201825137-138P2-060: Hepatitis C virus reinfection after successful treatment with all-oral, direct-acting antiviral therapy in a large population-based cohort including people who inject drugs,
Antiviral Research10.1016/0166-3542(93)90602-f199320163224 Treatment of chronic woodchuck hepatitis virus infection with thymosin alpha-1 (TA1),
Current Treatment Options in Infectious Diseases10.1007/s40506-020-00231-82020123296-309Hepatitis C Virus in the Elderly in the Direct-Acting Antiviral Era: from Diagnosis to CureMubeen Khan Mohammed Abdul, Heather S. Snyder, Mythili Chunduru, Susan M.K. Lee, Sanjaya K. Satapathy,,